Almac Diagnostic Services Limited Liability Company
United States Last updated 21 Oct 2026
- Devices
- 4
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
Repotrectinib Clinical Trial Assay (CTA) Ref Repotrectinib CTA
APOL1 Genotyping Clinical Trial Assay (CTA) Ref APOL1 Genotyping CTA
RARA Clinical Trial Assay (CTA) Ref RARA CTA
BIP SNP Clinical Trial Assay (CTA) Ref BIP SNP CTA
Related companies
Authorised representatives
About
Almac Diagnostic Services is a stratified medicine company specialising in biomarker driven clinical trials.
Frequently asked questions
How many devices does Almac Diagnostic Services Limited Liability Company have in the registry?
The registry currently lists 4 devices for Almac Diagnostic Services Limited Liability Company. Devices recorded under merged duplicate company entries are counted once.
Which registries list Almac Diagnostic Services Limited Liability Company's devices?
Among its 4 most recently registered devices, Almac Diagnostic Services Limited Liability Company has devices listed in EUDAMED (4 devices).
What risk classes do Almac Diagnostic Services Limited Liability Company's devices fall under?
Among its 4 most recently registered devices, the classes recorded for Almac Diagnostic Services Limited Liability Company's devices are IVD general. Each device page shows its own class and authorisation.
What are the newest devices from Almac Diagnostic Services Limited Liability Company in the registry?
The most recently registered devices listed for Almac Diagnostic Services Limited Liability Company include Repotrectinib Clinical Trial Assay (CTA), APOL1 Genotyping Clinical Trial Assay (CTA), RARA Clinical Trial Assay (CTA) and BIP SNP Clinical Trial Assay (CTA).
Information
- Address
- 4238, Technology Drive, Durham, United States
- Website
- www.almacgroup.com/diagnostics/
- [email protected]
- Phone
- +1 (919) 479 8850
- PRRC contact
- Katarina Wikstrom
- EUDAMED SRN
- US-MF-000025491